<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>497</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11342547</PubmedId>
            <Abstract>Detailed knowledge on antibody-antigen recognition is scarce given the unlimited antibody specificities of which only few have been investigated at an atomic level. We report the crystal structures of an antibody fragment derived from a camel heavy chain antibody against carbonic anhydrase, free and in complex with antigen. Surprisingly, this single-domain antibody interacts with nanomolar affinity with the antigen through its third hypervariable loop (19 amino acids long), providing a flat interacting surface of 620 A(2). For the first time, a single-domain antibody is observed with its first hypervariable loop adopting a type-1 canonical structure. The second hypervariable loop, of unique size due to a somatic mutation, reveals a regular beta-turn. The third hypervariable loop covers the remaining hypervariable loops and the side of the domain that normally interacts with the variable domain of the light chain. Specific amino acid substitutions and reoriented side chains reshape this side of the domain and increase its hydrophilicity. Of interest is the substitution of the conserved Trp-103 by Arg because it opens new perspectives to 'humanize' a camel variable domain of heavy chain of heavy chain antibody (VHH) or to 'camelize' a human or a mouse variable domain of heavy chain of conventional antibody (VH).</Abstract>
            <ArticleYear>2001</ArticleYear>
            <ArticlePages>26285-90</ArticlePages>
            <ArticleTitle>Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Desmyter</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Decanniere</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Muyldermans</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Wyns</LastName>
                    <ForeName>L</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department Ultrastructure, Vlaams Interuniversitair Instituut voor Biotechnologie, Vrije Universiteit Brussel, Paardenstraat 65, B-1640 Sint Genesius Rode, Belgium. aldesmtr@vub.ac.be</Affiliations>
            <ArticleChemicalList>Antibodies;Carbonic Anhydrases</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies(genetics; immunology); Antibody Affinity; Antibody Specificity; Camelids, New World; Carbonic Anhydrases(immunology); Humans; Molecular Sequence Data; Mutation; Sequence Alignment</ArticleMeshHeadingsList>
            <Journal>
                <Volume>276</Volume>
                <Issue>28</Issue>
                <Title>The Journal of biological chemistry</Title>
                <Issn>1083-351X</Issn>
                <MedlineTa>J Biol Chem</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>CA2 - cAb-CA05 VHH</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>P46, L47, S48, V49, S50, Y51, D52, D179, R181, G182, L184, P185, E186</DiscontinuousResidues>
                        <SourceMolecule>
                            <IedbAccession>SRC293733</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>9913</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table II</LocationOfData>
                <EpitopeId>241578</EpitopeId>
                <ReferenceRegion>P46, L47, S48, V49, S50, Y51, D52, D180, R182, G183, L185, P186, E187</ReferenceRegion>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The manuscript describes the antigen as bovine CA2, but the sequence provided in the PDB and the residues described in the text match the human CA2 sequence and not its bovine counterpart. It may be due to the fact that the structure was refined using the human CA2 structure as template. Therefore, the human sequence was assigned to Bos taurus as its organism for curation purposes. The PDB numbering has an error which displaces the author's positions from the Genebank positions in the last six residues of the epitope.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table II</LocationOfData>
                        <BCellId>1491564</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9838</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <IedbAccession>SRC293733</IedbAccession>
                                            </Molecule>
                                            <SourceOrganismId>9913</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Internal Identifier-no external match available</ImmunogenEvidenceCode>
                                <DoseSchedule>9 doses of 1 mg every 7 days</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunization is described in Lauwereys et al, EMBO J. 1998 17(13):3512 [PMID: 9649422].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.5</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>VH Domain</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>cAb-CA05</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>Heavy Isotype n/s</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>cAb-CA05</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1F2X_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9838</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <SourceOrganismId>9838</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <IedbAccession>SRC293733</IedbAccession>
                                        </Molecule>
                                        <SourceOrganismId>9913</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Internal Identifier-no external match available</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1G6V</ComplexPdbId>
                            <AntibodyChain1PdbChain>K</AntibodyChain1PdbChain>
                            <AntigenChainPdbChain>A</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>Details of atomic contacts are not provided in the paper. The structure of the cAb-CA05 antibody in this complex is the same as the uncomplexed structure [PDB:1F2X].</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>A: P46, L47, S48, V49, S50, Y51, D52, D180, R182, G183, L185, P186, E187;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>K: T898:H3, V899:H3, A900:H3, S901:H3, T902:H3, G903:H3, W904:H3, R907:H3, R909:H3, D912:H3, H914:H3</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>A: P46, L47, S48, V49, S50, Y51, D52, D180, R182, G183, L185, P186, E187, L189</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>K: Y832, T898, V899, A900, S901, T902, G903, W904, R907, R909, D912, H914, Y915</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>559.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>575.1</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

